Literature DB >> 32540348

Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.

Dinesh M Pardhi1, Didem Şen Karaman2, Juri Timonen3, Wei Wu4, Qi Zhang5, Saurabh Satija6, Meenu Mehta6, Nitin Charbe7, Paul A McCarron8, Murtaza M Tambuwala8, Hamid A Bakshi8, Poonam Negi9, Alaa A Aljabali10, Kamal Dua11, Dinesh K Chellappan12, Ajit Behera13, Kamla Pathak14, Ritesh B Watharkar15, Jarkko Rautio3, Jessica M Rosenholm16.   

Abstract

This review details the antimicrobial applications of inorganic nanomaterials of mostly metallic form, and the augmentation of activity by surface conjugation of peptide ligands. The review is subdivided into three main sections, of which the first describes the antimicrobial activity of inorganic nanomaterials against gram-positive, gram-negative and multidrug-resistant bacterial strains. The second section highlights the range of antimicrobial peptides and the drug resistance strategies employed by bacterial species to counter lethality. The final part discusses the role of antimicrobial peptide-decorated inorganic nanomaterials in the fight against bacterial strains that show resistance. General strategies for the preparation of antimicrobial peptides and their conjugation to nanomaterials are discussed, emphasizing the use of elemental and metallic oxide nanomaterials. Importantly, the permeation of antimicrobial peptides through the bacterial membrane is shown to aid the delivery of nanomaterials into bacterial cells. By judicious use of targeting ligands, the nanomaterial becomes able to differentiate between bacterial and mammalian cells and, thus, reduce side effects. Moreover, peptide conjugation to the surface of a nanomaterial will alter surface chemistry in ways that lead to reduction in toxicity and improvements in biocompatibility.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotics; Antimicrobial; Antimicrobial peptides; Conjugates; Nanomaterial

Year:  2020        PMID: 32540348     DOI: 10.1016/j.ijpharm.2020.119531

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis.

Authors:  Yinghan Chan; Sin Wi Ng; Meenu Mehta; Krishnan Anand; Sachin Kumar Singh; Gaurav Gupta; Dinesh Kumar Chellappan; Kamal Dua
Journal:  Med Hypotheses       Date:  2020-09-24       Impact factor: 1.538

Review 2.  Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases.

Authors:  Daljeet Singh Dhanjal; Parvarish Sharma; Meenu Mehta; Murtaza M Tambuwala; Parteek Prasher; Keshav R Paudel; Gang Liu; Shakti D Shukla; Philip M Hansbro; Dinesh Kumar Chellappan; Kamal Dua; Saurabh Satija
Journal:  Future Med Chem       Date:  2022-01-12       Impact factor: 3.808

Review 3.  Ag-Based Synergistic Antimicrobial Composites. A Critical Review.

Authors:  Ekaterina A Kukushkina; Syed Imdadul Hossain; Maria Chiara Sportelli; Nicoletta Ditaranto; Rosaria Anna Picca; Nicola Cioffi
Journal:  Nanomaterials (Basel)       Date:  2021-06-27       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.